Dr. Mark Socinski, MD
Claim this profileAdventHealth Orlando
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
10 reported clinical trials
14 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
HER2 positive
2Non-Small Cell Lung Cancer
Stage IV
Stage III
EGFR positive
Affiliated Hospitals
Clinical Trials Mark Socinski, MD is currently running
ONC-392 vs Chemotherapy
for Lung Cancer
This trial is testing gotistobart, a new drug that helps the immune system fight advanced lung cancer in patients who haven't responded to other treatments. It works by blocking a protein that allows cancer cells to hide from the immune system.
Recruiting2 awards Phase 310 criteria
APL-101
for Lung Cancer
This trial is testing APL-101, a new drug, on patients with specific genetic changes in their cancer. These patients often don't respond to typical treatments. The drug aims to block a protein that helps cancer cells grow and spread.
Recruiting1 award Phase 211 criteria
More about Mark Socinski, MD
Clinical Trial Related6 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Mark Socinski, MD has experience with
- Pembrolizumab
- Docetaxel
- ONC-392
- Ociperlimab
- Placebo
- Tislelizumab
Breakdown of trials Mark Socinski, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Pancreatic Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark Socinski, MD specialize in?
Mark Socinski, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Mark Socinski, MD currently recruiting for clinical trials?
Yes, Mark Socinski, MD is currently recruiting for 3 clinical trials in Orlando Florida. If you're interested in participating, you should apply.
Are there any treatments that Mark Socinski, MD has studied deeply?
Yes, Mark Socinski, MD has studied treatments such as Pembrolizumab, Docetaxel, ONC-392.
What is the best way to schedule an appointment with Mark Socinski, MD?
Apply for one of the trials that Mark Socinski, MD is conducting.
What is the office address of Mark Socinski, MD?
The office of Mark Socinski, MD is located at: AdventHealth Orlando, Orlando, Florida 32804 United States. This is the address for their practice at the AdventHealth Orlando.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.